Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists
Peptide Analgesics – Opioid Peptides
Elucidating the active δ-opioid receptor crystal structure with peptide and small-molecule agonists | Science Advances
Kinase cascades and ligand-directed signaling at the kappa opioid receptor. - Abstract - Europe PMC
Diverse Kappa Opioid Receptor Agonists: Relationships Between Signaling and Behavior
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
κ-opioid receptor - Wikipedia
Novel Mixed NOP/Opioid Receptor Peptide Agonists | Journal of Medicinal Chemistry
Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? - Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain | Journal of Neuroscience
Enhancing Remyelination through a Novel Opioid-Receptor Pathway | Journal of Neuroscience
Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion | Semantic Scholar
Molecules | Free Full-Text | Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Opioid Receptor | kappa, mu Opioid Receptor
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
κ-opioid receptor - Wikipedia
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Antagonists of the kappa opioid receptor - ScienceDirect
Kappa Opiate Receptor - an overview | ScienceDirect Topics
Kappa Receptors – Opioid Peptides
Peripheral Kappa Opioid Receptor Signaling Takes on a Central Role - ScienceDirect
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Nephrology Journal Club on Twitter: "Difelikefalin (CR845) (KORSUVA) is a peripherally restricted, selective kappa opioid receptor agonist that exerts antipruritic effects by means of activation of kappa opioid receptors on peripheral neurons
